Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin

Exclusion Criteria

• •Type 1 diabetes mellitus
• •HbA1c \< 7% or \> 10%
• •Fasting plasma glucose \> 250 mg/dL (\> 13.9 mmol/L)
• •Age \<18 years or Age ≥ 80 years
• •Patients who have not been on stable daily dose of at least 1500 mg metformin within 3 months prior to screening
• •Patients currently receiving or who have received anti-diabetic drugs other than metformin within 3 months prior to screening
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.